Skip Navigation

Advertise|Press|Contact|FAQ|About Us

Bookmark/Print/Share

Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Immunology | Musculoskeletal | Rheumatology | Nephrology
Disease Category: Systemic Lupus Erythematosus
Location: United States, NY

Clinical Trial Details

Overview

Research Study Summary

Systemic Lupus Erythematosus (SLE)

Purpose

Patients with Systemic Lupus Erythematosus (SLE) are asked to participate in the ILLUMINATE research study program being conducted by The Feinstein Institute for Medical Research.

You may be eligible to participate in this study if you:

  • Are at least 18 years old
  • Have been diagnosed with systemic lupus Erythematosus (SLE)

Individuals who qualify will receive study medication and all study-related care at no charge. Reimbursement for study-related travel and time will be provided. Some standard lupus medications will also be permitted during study participation.

Exclusion Criteria

  • None submitted by site

To Learn more
Gender

Both Male and Female

Age

18 and up

Overall Status

Recruiting

Facility Type

N/A

Contact

Sanita Kandasami, Study Coordinator
Biomedical Research Alliance of New York
Feinstein Institute for Medical Research,
350 Community Drive,
Manhasset, NY 11030
Phone: 516-562-2401
Fax: 516-562-2537

View Map

Research Center Information: Biomedical Research Alliance of New York

If you would like to learn more about participating in this research study, please email the trial contact using the form below.

Name:
Address:
City:
State:
Zip/Postal Code:
Country:
Phone:
Email:  
Message:
 
Please leave this field empty.

CW ID: 170219

Date Last Changed: July 23, 2013


DISCLAIMER: CenterWatch does not conduct clinical research. CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies, contract research organizations, clinical research sites and other interested parties. This information is designed to help patients find clinical trials of interest and contact the research centers conducting the trials.